BioCentury
ARTICLE | Clinical News

Oral interferon-alpha: Update

November 12, 2001 8:00 AM UTC

Amarillo Biosciences Inc. (AMAR), Amarillo, Texas Product: Oral interferon-alpha Business: Respiratory Therapeutic category: Immune modulation Target: Unknown Description: Oral formulation of interfer...